Dan Ives at Wedbush expects Tesla Inc. TSLA, -0.15% to report a profit when it reports second quarter earnings on Wednesday, which ultimately results in the company joining the S&P 500 SPX index, + 0.32%. The inclusion of the S&P 500 “is already considered a fait accompli among the bulls,” …
Read More »AstraZeneca stocks drop 3% as results of early-stage study on coronavirus vaccine released
Shares of AstraZeneca AZN, -0.75% AZN + 3.16% They fell 3.4% in trade on Monday after a medical journal published a study that found the company’s COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a phase 1/2 clinical trial. . AstraZeneca is developing the experimental vaccine with …
Read More »AstraZeneca climbs as GlaxoSmithKline relaxes as the FTSE 100 glides
Prince William, Duke of Cambridge, wears a face mask as a precaution against the spread of COVID-19 and speaks to a patient participating in a COVID-19 vaccine trial at the Oxford Vaccine Group facility in Oxford, England, June 24, 2020. Steve Parsons / Agence France-Presse / Getty Images AstraZeneca and …
Read More »BioNTech, Pfizer Shares Meeting On Preliminary Data Showing Candidate T-Cell Response To Coronavirus Vaccine
BioNTech BNTX Shares, + 3.95% and Pfizer Inc. PFE, + 1.46% Both were launched into pre-market trade on Monday after companies said their experimental COVID-19 vaccine elicited a T-cell response in people participating in a phase 1/2 clinical trial in Germany. The vaccine candidate also again demonstrated that it can …
Read More »Abbott, J&J results were fueled by June’s surprising surge in medical procedures, even as coronavirus cases rise
Abbott Laboratories and Johnson & Johnson separately reported recoveries from elective procedures earlier than expected in US hospitals in the second quarter, even as the nation struggles with an increasingly severe COVID-19 pandemic. Shares of Abbott ABT, + 2.95% closed at a year-to-date high of $ 99.25, the day after …
Read More »